Back to Search
Start Over
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
- Source :
- Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group, 2022.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20511426
- Volume :
- 10
- Issue :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- Journal for ImmunoTherapy of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.b9a84246b2264ed1b2c2acbbf2f19d79
- Document Type :
- article
- Full Text :
- https://doi.org/10.1136/jitc-2022-004495